Impact Protein intake on growth in Cystic Fibrosis

Impact Protein intake on growth in Cystic Fibrosis - Impact Protein intake on height growth in Cystic Fibrosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON33049

Enrollment

Registered

2009-11-24

Start date

2009-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Interventions

Each patient will receive in random order above the normal recommended feeding intake 2 g protein extra * kg*1 * d*1 in the form of protein powder. The energy, fat and carbohydrate intakes stay the

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: * Boys and girls with the age 4*12 y * Prepubertal status * Mild lung disease (FEV1 >75%) * Informed consent signed by parents

Exclusion criteria

Exclusion criteria: * Possible use of Corticosteroid

Design outcomes

Primary

Measure	Time frame
The main study parameters are the differences in heigth and lean body mass. Based on these parameters, the growth will be determined. The side effect parameters are the differences in weight and urea.	—

Secondary

Measure	Time frame
The side effect parameters are the differences in weight and urea.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)